(Q34368408)
Statements
1 reference
Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer (English)
1 reference
Michael J Morris
Josef J Fox
Daniel C Danila
Susan F Slovin
Jeffrey H Hager
Peter J Rix
Edna Chow Maneval
Isan Chen
Mithat Gönen
Martin Fleisher
Charles L Sawyers
Howard I Scher
3 September 2013
1 reference